Table 2.
Five Tear Observed Progression Free Survival (Kaplan-Meier) and Restricted Mean Survival Time (RMST) According to Minimal Residual Disease Sub-Type
Variable Predictor | % PFS 5 years Kaplan-Meier (95% CI) |
Observed RMST 5 years (95% CI) |
|
---|---|---|---|
I CTC (-) mM (-) | 98.1% | 4.91 years | |
N=105 | (87.1-99.7%) | (4.76-5.08) | |
Prognostic Group | |||
II CTC (-) mM (+) | 62.7% | 4.12 years | |
N=36 | (37.3-80.2%) | (3.55-4.70) | |
III CTC (+) | 7.0% | 1.71 years | |
N=40 | (0.5-26.2%) | (1.19-2-23) |
%, percentage; CI, confidence interval; CTC, circulating tumour cell; mM, micro-metastasis; RMST is the area under the Kaplan-Meier survival curve determined by the